Sign in or register to see full information and data.

Studies / CAVD 435


Study information

Grant Affiliation:Nussenzweig: Discovery & Characterization of bNAbs
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2013-12-20
Study Made Public:2015-08-28


Neutralization and Binding Data for 4 Germline Versions of bNAbs from HIV-Infected Patients


CAVD 435 is an immunogenicity study of broadly neutralizing antibodies to investigate the development of four germline versions of broadly neutralizing antibodies (bNAbs) that were previously identified in HIV-infected patients.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.